About Omnicare (NYSE:OCR)
Omnicare, Inc. is a healthcare services company that specializes in the management of complex pharmaceutical care. The Company operates two primary businesses, Long-Term Care Group (LTC) and Specialty Care Group (SCG), each serving different customer populations. Through LTC, the Company is a provider of pharmaceuticals and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. As of December 31, 2014, LTC provided pharmacy services in the United States in 47 states and the District of Columbia. The Specialty Care Group (SCG) operates across a spectrum of the healthcare continuum, serving the needs of biopharmaceutical manufacturers, physicians, nurses, caregivers and patients. Its SCG services are primarily focused on the specialty pharmaceutical market and incorporate four platforms: brand support services, supply chain solutions, patient support services and specialty pharmacy.
Industry, Sector and Symbol
Sub-IndustryHealth Care Services
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity5.37%
Return on Assets2.20%
Omnicare (NYSE:OCR) Frequently Asked Questions
What is Omnicare's stock symbol?
Omnicare trades on the New York Stock Exchange (NYSE) under the ticker symbol "OCR."
How were Omnicare's earnings last quarter?
Omnicare, Inc. (NYSE:OCR) released its quarterly earnings data on Wednesday, February, 19th. The healthcare company reported $0.87 earnings per share for the quarter, missing analysts' consensus estimates of $0.90 by $0.03. The healthcare company earned $1.54 billion during the quarter, compared to analysts' expectations of $1.59 billion. Omnicare had a net margin of 1.96% and a return on equity of 5.37%. View Omnicare's Earnings History.
Has Omnicare been receiving favorable news coverage?
Media stories about OCR stock have been trending somewhat positive this week, according to Accern Sentiment. The research firm identifies positive and negative media coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Omnicare earned a news sentiment score of 0.01 on Accern's scale. They also assigned media headlines about the healthcare company an impact score of 44.49 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Omnicare?
Shares of OCR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Omnicare's stock price today?
One share of OCR stock can currently be purchased for approximately $97.90.
How big of a company is Omnicare?
Omnicare has a market capitalization of $9.48 billion.
How can I contact Omnicare?
Omnicare's mailing address is 900 Omnicare Center 201 E. Fourth Street, CINCINNATI, OH 45202-4248, United States. The healthcare company can be reached via phone at +1-513-7192600.
MarketBeat Community Rating for Omnicare (OCR)MarketBeat's community ratings are surveys of what our community members think about Omnicare and other stocks. Vote "Outperform" if you believe OCR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OCR will underperform the S&P 500 over the long term. You may vote once every thirty days.
Omnicare (NYSE:OCR) Dividend Information
Omnicare pays an annual dividend of $0.00 per share, with a dividend yield of 0.00%. OCR's most recent quarterly dividend payment was Tuesday, June 30.
|Most Recent Dividend:||6/30/2015|
|Dividend Growth:||0.00% (3 Year Average)|
Omnicare (NYSE:OCR) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Omnicare (NYSE:OCR) SEC Filings
This page is loading this company's SEC Filings. Please wait...